Spots Global Cancer Trial Database for To Assess the Impact of theERAS Consensus on Patients With Endoscopic Pituitary Tumor Surgery

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: To Assess the Impact of theERAS Consensus on Patients With Endoscopic Pituitary Tumor Surgery

Official Title: To Assess the Impact of the Enhanced Recovery After Surgery (ERAS) Consensus on the Effectiveness and Prognosis of Patients With Endoscopic Pituitary Tumor Surgery

Study ID: NCT06221020

Conditions

Enhanced Recovery After Surgery

Pituitary Tumor

Postoperative Complications

Interventions

Malnutrition Universal Screening Tool

TIB Olfactory Test Device

Apfel Score for Postoperative nausea and vomiting

The American Society of Anesthesiologists (ASA) Physical Status Classification

Short Form-36

World Health Organization Quality of Life questionnaire (WHOQOL-BREF)

BDI-II(Beck Depression Inventory-II)

ERAS Patient Satisfaction Questionnaire(ERAS-PSQ)

Quality of Recovery-40(QoR-40)

Study Description

Brief Summary: The goal of this observational study is to evaluate the effectiveness and impact of Enhanced Recovery After Surgery (ERAS) on patients with pituitary gland tumors.

Detailed Description: The goal of this observational study is to evaluate the effectiveness and impact of Enhanced Recovery After Surgery (ERAS) on patients with pituitary gland tumors. This study is particularly significant as ERAS has been a prominent focus in international medical treatment, emphasizing improved patient recovery and safety. The main questions it aims to answer are: How does ERAS affect the effectiveness and prognosis of patients with pituitary gland tumors? Which specific inspection and evaluation items within the ERAS protocol genuinely assist patients? Participants in this study will undergo various ERAS protocols, including pre-operative to post-operative rehabilitation measures, pain management, surgical techniques, and early resumption of eating and activities. This comprehensive approach is designed to reduce complications, shorten hospital stays, and speed up patient recovery. Additionally, this study will conduct a thorough statistical analysis to determine which aspects of the ERAS protocol are most beneficial. By comparing the outcomes of patients undergoing the ERAS protocol with those who do not, researchers aim to understand better the balance between ERAS and the Choosing Wisely initiative, which advocates for reducing unnecessary medical interventions. This research is crucial in advancing medical knowledge and practice, particularly in managing pituitary gland tumors, and contributes to the broader goals of enhancing medical quality and patient safety.